| 1 |
Donald Todd |
Arcsecond |
3 |
| 1 |
Raymond F. Watts |
ExxonMobil |
3 |
| 3 |
Kirk S. Kealey |
Mars, Incorporated |
2 |
| 3 |
Laura J. Crane |
Schering-Plough Healthcare Products |
2 |
| 3 |
Dennis D. Jamiolkowski |
Johnson & Johnson |
2 |
| 3 |
Robert T. Stibrany |
ExxonMobil |
2 |
| 3 |
Tina deVries |
Rvl Pharmaceuticals |
2 |
| 3 |
George Pawlo |
Delsys Pharmaceutical |
2 |
| #9 |
Jennifer Sturgeon |
Mcneil-Ppc |
1 |
| #9 |
Dennis Smithyman |
The Boc Group Limited |
1 |
| #9 |
Arthur M. P. Doweyko |
Bristol-Myers Squibb |
1 |
| #9 |
Walid Nabhane |
— |
1 |
| #9 |
Claudinei A. Fava |
Isp Investments |
1 |
| #9 |
Robert DiPaola |
Rutgers, The State University |
1 |
| #9 |
Carol Eversen |
AT&T |
1 |
| #9 |
Christopher Gieda |
West Pharmaceutical Services |
1 |
| #9 |
Keith A. Horn |
Alliedsignal |
1 |
| #9 |
Roger David Benning |
AT&T |
1 |
| #9 |
Eric John Diethorn |
Avaya |
1 |
| #9 |
Douglas J. Hanchett |
National Starch And Chemical Investment Holding Copporation |
1 |
| #9 |
Kirk Campbell |
Verizon |
1 |
| #9 |
Walter J. Kaminski |
AT&T |
1 |
| #9 |
Anthony Schiano |
AT&T |
1 |
| #9 |
Charles H. Trillich |
Trinity |
1 |
| #9 |
Roger M. Boissonneault |
Warner Chilcott Company |
1 |
| #9 |
Chris Constantine Tsamutalis |
AT&T |
1 |
| #9 |
David Milner |
Linde Gmbh |
1 |
| #9 |
Robert E. Witte |
AT&T |
1 |
| #9 |
Robert Kowtko |
Kulicke & Soffa Investments |
1 |
| #9 |
James J. Messina |
Unknown |
1 |
| #9 |
James Dirickson Mumford |
ExxonMobil |
1 |
| #9 |
Jeffrey Lynn |
Isp Investments |
1 |